Shree Ganesh Remedies share news, announcements and annual reports
NSE: SGRLBSE: 540737Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹639.75.
30 Oct: open ₹639.75, high ₹651.85, low ₹610.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹792 Cr1,715th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 65.44
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.78
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.16
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,62259.3% delivered
Shree Ganesh Remedies share news and announcements
464 announcements, routine notices left out, newest first. Page 2 of 10.
Aug 2025
8 Aug · Board meeting
2 Aug · Business
1 Aug · Results
Jul 2025
28 Jul · Board meeting
Meeting on 1 Aug 2025: quarterly results21 Jul · Announcement Under Regulation 30 Of SEBI Listing Regulations
May 2025
19 May · Business
19 May · Management
19 May · Results
19 May · Board meeting
17 May · Management
15 May · Analysts
12 May · Board meeting
Meeting on 19 May 2025: audited results
Apr 2025
26 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Mar 2025
25 Mar · Business
24 Mar · Analysts
Feb 2025
5 Feb · Business
5 Feb · Analysts
5 Feb · Corporate action
5 Feb · Results
5 Feb · Results
5 Feb · Results
Jan 2025
30 Jan · Business
29 Jan · Board meeting
Meeting on 5 Feb 2025: quarterly results1 Jan · Receipt Of Approval From BSE Limited For Forfeiture Of Equity Shares
Dec 2024
10 Dec · Business
3 Dec · Business
Nov 2024
4 Nov · Analysts
Oct 2024
30 Oct · Business
29 Oct · Business
29 Oct · Results
29 Oct · Results
24 Oct · Board meeting
Meeting on 29 Oct 2024: quarterly results8 Oct · Business
Sep 2024
30 Sep · Meeting
30 Sep · Meeting
28 Sep · Board meeting
26 Sep · Analysts
20 Sep · Board meeting
Meeting on 28 Sep 202416 Sep · Business
Aug 2024
30 Aug · Management
30 Aug · Board meeting